Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of$ 0.98 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +8.16%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 0.43 per share when it actually produced earnings of $0.08, delivering a surprise of -81.4%.Over the last fo ...